Ibrahim YH, Garcia-Garcia C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzman M, Grueso J, Rodriguez O, Calvo MT, Aura C, Diez O, Rubio IT, Perez J, Rodon J, Cortes J, Ellisen LW, Scaltriti M, Baselga J. PI3K Inhibition impairs BRCA-1/2 expression and sensitizes BRCA-proficient triplenegative breast cancer to PARP Inhibition. Cancer Discov. 2012 Nov;2(11):1036-47. - Stand Up To Cancer

Blog

Posted September 17, 2019

Ibrahim YH, Garcia-Garcia C, Serra V, He L, Torres-Lockhart K, Prat A, Anton P, Cozar P, Guzman M, Grueso J, Rodriguez O, Calvo MT, Aura C, Diez O, Rubio IT, Perez J, Rodon J, Cortes J, Ellisen LW, Scaltriti M, Baselga J. PI3K Inhibition impairs BRCA-1/2 expression and sensitizes BRCA-proficient triplenegative breast cancer to PARP Inhibition. Cancer Discov. 2012 Nov;2(11):1036-47.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.